CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The rise in the manufacturers of biologics
4.1.2. Increase in investments by major pharmaceutical companies
4.1.3. Increasing adoption of single-use technologies
4.1.4. Growth in the biopharmaceutical industry
4.2. Market Restraints & Challenges
4.2.1. Huge capital expenditure required to set up new production facilities
4.2.2. Strict government regulations for validation of filtration processes
4.3. Market Opportunities
4.3.1. Rising opportunities in emerging markets
4.3.2. Growing technological advancements in tangential flow filtration
CHAPTER 5. GLOBAL TANGENTIAL FLOW FILTRATION MARKET – BY
PRODUCT
5.1. Single-Use Systems
5.2. Reusable Systems
5.3. Membrane Filters
5.3.1 Cassettes
5.3.2 Cartridges
5.4 Filtration Accessories
CHAPTER 6. GLOBAL TANGENTIAL FLOW FILTRATION MARKET – BY
TECHNOLOGY
6.1. Ultrafiltration
6.2. Microfiltration
6.3. Reverse Osmosis
CHAPTER 7. GLOBAL TANGENTIAL FLOW FILTRATION MARKET – BY
MEMBRANE MATERIAL
7.1. Polyethersulfone
7.2. Regenerated Cellulose
7.3. Others
CHAPTER 8. GLOBAL TANGENTIAL FLOW FILTRATION MARKET – BY SIZE
8.1. Ultrafilters
8.2. Microfilters
8.3. Reverse Osmosis Filters
CHAPTER 9. GLOBAL TANGENTIAL FLOW FILTRATION MARKET – BY
APPLICATION
9.1. Bioprocessing
9.1.1 Product Concentration, Purification, and Diafiltration
9.1.2 Cell Harvesting & Cell Clarification
9.2. Viral Vectors and Vaccine Purification
9.3. Pharmaceutical Water Production
9.4. Other Applications
CHAPTER 10. GLOBAL TANGENTIAL FLOW FILTRATION MARKET - BY
GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11. GLOBAL TANGENTIAL FLOW FILTRATION MARKET - COMPANY
PROFILES
11.1. Sartorius Stedim Biotech S.A.
11.2. Parker Hannifin Corporation
11.3. Ge Healthcare
11.4. Alfa Laval AB
11.5. Koch Membrane Systems, Inc.
11.6. Novasep
11.7. Pendotech
11.8. Spectrum Laboratories, Inc.
11.9. Merck Millipore
11.10. Danaher Corporation
11.11. TangenX Technology Corporation
11.12. Sartorius AG.
11.13. Cesco Bio Engineering Co. Ltd
11.14. Applikon Biotechnology B.V
11.15. Thermo Fisher Scientific Inc.
CHAPTER 12. GLOBAL TANGENTIAL FLOW FILTRATION MARKET -
COMPETITIVE LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13. MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14. APPENDIX
14.1. List of Tables
14.2. List of Figures
